Skip to main content

Indian Health Officials Asks J&J To Reveal Talc Contents

Indian Health Officials Asks J&J To Reveal Talc Contents

Indian Health Officials Asks J&J To Reveal Talc Contents

Introduction

Indian health officials are demanding a detailed list of the ingredients used in Johnson & Johnson's Baby Powder and other talc-based products due to concerns over the alleged carcinogenic asbestos presence in their products. India’s Central Drugs Standard Control Organization (CDSCO) sent out an email on July 19, requesting J&J to reveal the talcum powder contents.

Though in a March 2016 review, CDSOC cleared the company's products of asbestos presence during an inspection of a J&J manufacturing plant in Mumbai, the concerns sour high following a recent $4.7 billion verdict in a talcum trial in Missouri linked to ovarian cancer claims by 22 women.

Currently, there are two separate allegations against J&J, one regarding asbestos presence in their talc-based products causing ovarian cancer in women using it for personal hygiene purpose and the other linked to asbestos exposure causing mesothelioma, a fatal lung cancer. However, J&J continues to deny that their talcum products contain cancer-causing asbestos in them and plans to appeal all the jury verdicts against them.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!